Abstract

BackgroundWe describe trends in characteristics and outcomes among adults initiating HIV care and treatment in Ethiopia from 2006-2011.MethodsWe conducted a retrospective longitudinal analysis of HIV-positive adults (≥15 years) enrolling at 56 Ethiopian health facilities from 2006–2011. We investigated trends over time in the proportion enrolling through provider-initiated counseling and testing (PITC), baseline CD4+ cell counts and WHO stage. Additionally, we assessed outcomes (recorded death, loss to follow-up (LTF), transfer, and total attrition (recorded death plus LTF)) before and after ART initiation. Kaplan-Meier techniques estimated cumulative incidence of these outcomes through 36 months after ART initiation. Factors associated with LTF and death after ART initiation were estimated using Hazard Ratios accounting for within-clinic correlation.Results93,418 adults enrolled into HIV care; 53,300 (57%) initiated ART. The proportion enrolled through PITC increased from 27.6% (2006–2007) to 44.8% (2010–2011) (p < .0001). Concurrently, median enrollment CD4+ cell count increased from 158 to 208 cells/mm3 (p < .0001), and patients initiating ART with advanced WHO stage decreased from 56.6% (stage III) and 15.0% (IV) in 2006–2007 to 47.6% (stage III) and 8.5% (IV) in 2010–2011. Median CD4+ cell count at ART initiation remained stable over time. 24% of patients were LTF before ART initiation. Among those initiating ART, attrition was 30% after 36 months, with most occurring within the first 6 months. Recorded death after ART initiation was 6.4% and 9.2% at 6 and 36 months, respectively, and decreased over time. Younger age, male gender, never being married, no formal education, low CD4+ cell count, and advanced WHO stage were associated with increased LTF. Recorded death was lower among younger adults, females, married individuals, those with higher CD4+ cell counts and lower WHO stage at ART initiation.ConclusionsOver time, enrollment in HIV care through outpatient PITC increased and patients enrolled into HIV care at earlier disease stages across all HIV testing points. However, median CD4+ cell count at ART initiation remained steady. Pre- and post-ART attrition (particularly in the first 6 months) have remained major challenges in ensuring prompt ART initiation and retention on ART.

Highlights

  • We describe trends in characteristics and outcomes among adults initiating HIV care and treatment in Ethiopia from 2006-2011

  • We aim to describe trends over time in enrollment of adults identified through provider-initiated counseling and testing (PITC) vs. VCT testing approaches, key demographic and clinical trends at enrollment into HIV care and at antiretroviral treatment (ART) initiation, as well as outcomes after enrollment in care and ART initiation

  • Variables hypothesized a priori to change over time as a result of PITC scale-up (WHO stage and CD4+ cell count at enrollment into care/ART initiation, PITC and VCT point of entry) CD4 were tested for trends over time using univariate linear mixed models with a random effect to account for with-site correlations

Read more

Summary

Introduction

We describe trends in characteristics and outcomes among adults initiating HIV care and treatment in Ethiopia from 2006-2011. Trends over time and characteristics of the patient population seeking HIV care in Ethiopia have been under-reported in the literature compared with higherprevalence countries in sub-Saharan Africa. Several reports have focused on individual hospitals or health centers in Ethiopia [5,6,7,8,9], using aggregate-level national reporting data [10,11,12,13], or sampling methodologies to obtain patient-level information on a subset of key outcomes [14]. Large-scale multi-regional assessments of the adult population seeking HIV care using routinely-collected patient-level data in Ethiopia have not been reported

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call